Evidence map›Paper›PMID 17544292›Full record

ReviewPharmacological research2007

Protein kinase C theta (PKCtheta): a key player in T cell life and death.

Keitaro Hayashi, Amnon Altman

Open access · greenAbstract readReview
In one paragraph

Review in Pharmacological research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 2 syntheses or guidelines pooled it, 185 citations in OpenAlex.

  1. Cross-phenotype analysis of Immunochip data identifiesAnnals of the rheumatic diseases · 2018
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Applications of oxetanes in drug discovery and medicinal chemistry.European journal of medicinal chemistry · 2023
    Review
  12. Article
  13. Computational analysis of regulatory regions in human protein kinases.Protein science : a publication of the Protein Society · 2023
    Article
  14. Article
  15. Review
  16. Article
  17. Early Transcriptomic Response to Burn Injury: Severe Burns Are Associated With Immune Pathway Shutdown.Journal of burn care & research : official publication of the American Burn Association · 2022
    Article
  18. Article
  19. Article
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Keitaro HayashiDivision of Cell Biology, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA.
Amnon Altman
La Jolla Institute for Immunology · US

Funding

T CELLS AND THEIR LYMPHOKINES IN CANCER IMMUNOTHERAPYR01CA035299 · NCI · SCRIPPS RESEARCH INSTITUTE · PI ALTMAN, AMNON · 1985 to 2013
$3.8M
NCI NIH HHS CA35299NCI NIH HHS R01 CA035299
6 · The paper itself

Abstract

Protein kinase C theta (PKCtheta) is a member of the novel, Ca(2+)-independent PKC subfamily, which plays an important and non-redundant role in several aspects of T cell biology. Much progress has been accomplished in understanding the function of PKCtheta in the immune system and its unique translocation to the immunological synapse in Ag-stimulated T lymphocytes. Biochemical and genetic approaches revealed that PKCtheta is required for the activation of mature T cells as well as for their survival. Mutation of the PKCtheta gene leads to impaired receptor-induced stimulation of the transcription factors AP-1, NF-kappaB and NFAT, which results in defective T cell activation, and to aberrant expression of apoptosis-related proteins, resulting in poor T cell survival. Furthermore, PKCtheta-deficient mice display defects in the differentiation of T helper subsets, particularly in Th2- and Th17-mediated inflammatory responses. Therefore, PKCtheta is a critical enzyme that regulates T cell function at multiple stages, and it represents an attractive drug target for allergic and autoimmune diseases.

Indexed as

AnimalsApoptosisCell DifferentiationCell SurvivalHumansIsoenzymesLymphocyte ActivationMiceMutationProtein Kinase CProtein Kinase C-thetaSignal TransductionT-LymphocytesIsoenzymesPRKCQ protein, humanPrkcq protein, mouseProtein Kinase CProtein Kinase C-theta

Identifiers

PMID17544292
PMCPMC2045646
OpenAlexW2090757010

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.